HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prisca Gnamlin Selected Research

Neoplasms (Cancer)

11/2019Long non-coding RNA GAS5 acts as proliferation "brakes" in CD133+ cells responsible for tumor recurrence.
1/2018Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.
5/2013Treatment of malignant effusion by oncolytic virotherapy in an experimental subcutaneous xenograft model of lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Prisca Gnamlin Research Topics

Disease

3Neoplasms (Cancer)
11/2019 - 05/2013
1Neoplasm Metastasis (Metastasis)
11/2019
1Tics (Tic)
11/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2018
1Virus Diseases (Viral Diseases)
05/2013
1Malignant Pleural Effusion
05/2013
1Lung Neoplasms (Lung Cancer)
05/2013
1Adenocarcinoma of Lung
05/2013

Drug/Important Bio-Agent (IBA)

1Long Noncoding RNAIBA
11/2019
114-O-phosphonooxymethyltriptolide disodium saltIBA
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2013

Therapy/Procedure

2Therapeutics
11/2019 - 05/2013
1Drug Therapy (Chemotherapy)
11/2019
1Oncolytic Virotherapy
05/2013